Equity firm invests $200M to launch independent cancer care network

Private equity firm General Atlantic has agreed to invest $200 million in Nashville, Tenn.-based OneOncology, a startup that aims to manage independent cancer treatment clinics, according to The Wall Street Journal.

Advertisement

The company’s founders and first customers are three cancer treatment practices in New York and Tennessee. The $200 million investment makes General Atlantic the majority owner of the startup, according to the report.

“With the launch of OneOncology, we hope to transform the future of cancer care,” Tracy Bahl, OneOncology’s president and CEO, said in a press release. “Cancer is increasingly being treated like a chronic condition rather than a terminal diagnosis. Working together with world-class oncologists, we will drive the change that community cancer needs through continual learning, creative and smart evolution, and a collective desire to positively impact the lives of every person touched by cancer.”

More articles on healthcare finance:

12 hospitals with strong finances
Cash-strapped California hospital to close ER Sept. 16
MU Health Care’s annual revenue hits $1B for first time

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.